Startup profile for Navan: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.
Venture Capital Tracker logo
Venture Capital Tracker

Startup profile · funding coverage

Navan funding, valuation and investors

Corporate travel and expense management platform (formerly TripActions).

Keep track of Navan

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Series G

$300M · October 2022

Latest known valuation

Not publicly disclosed

Total disclosed equity funding

$575M

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

private

growth · Palo Alto, CA

Investors in latest funding

Lead: Coatue

Other: Andreessen Horowitz

Sources: latest funding Last verified: 2026-07-25

Overview

Navan (formerly TripActions) provides corporate travel booking, expense management, and payment cards for enterprises. Founded in 2015, it rebranded from TripActions to Navan in 2022. Andreessen Horowitz participated across multiple rounds including Series F ($275M, 2021) and later financings with Coatue and Lightspeed.

Why Navan is interesting

Modernized corporate T&E for enterprises — a16z early backer as company scaled to unicorn; AI agent features now central to roadmap for booking and policy automation.

Product & use cases

Navan combines corporate travel booking, expense reporting, virtual payment cards, and policy enforcement in one platform — replacing fragmented T&E tools with integrated booking-to-reconciliation workflow.

  • Corporate travel booking with policy compliance
  • Automated expense reporting and reconciliation
  • Virtual cards for travel and business spend

Key facts

  • Series F (Oct 2021): $275M led by Greenoaks; a16z participated — Navan press
  • Rebranded from TripActions to Navan in 2022
  • Series G (Oct 2022): $300M with Coatue and a16z

Funding history (newest first)

Series G

2022-10 $300M

Source: https://navan.com/press/

Series F

2021-10 $275M

Source: https://navan.com/press/series-f

Investors in our directory

Funds linked from Navan's profile — open a fund page for stage focus and related deal articles.

Andreessen Horowitz Coatue Lightspeed Venture Partners

Competitive landscape

Edge: Integrated travel + expense + payments in one platform — reduces friction vs. separate Concur + booking tools.

Corporate T&E is massive but dominated by Concur in enterprise. Navan/TripActions won growth-company accounts with modern UX. AI booking agents are the next battleground across Navan, Concur, and startups.

  • SAP Concur incumbent

    Enterprise T&E market leader.

  • Expensify direct

    Expense management for SMBs.

  • TravelPerk direct

    Corporate travel platform.

  • Brex adjacent

    Corporate cards; less travel booking depth.

Notable stories

  • Navan rebranded from TripActions in 2022 to reflect expansion beyond travel into full corporate spend management.

Industries

Enterprise SaaS Fintech

FAQs about Navan

Practical answers founders, operators, and investors typically search for.

Corporate travel and expense management platform (formerly TripActions).
Same company — rebranded to Navan in 2022.
a16z (/fund/andreessen-horowitz), Coatue (/fund/coatue), and Lightspeed (/fund/lightspeed-venture-partners-nyc) among investors.
Concur is enterprise incumbent. Navan targets modern UX and integrated travel+expense.
2015 as TripActions, Palo Alto.
Not publicly disclosed; late-stage private.
Yes — virtual and physical cards integrated with T&E.
Enterprise and mid-market companies — logos on navan.com.
Yes — AI features for booking, policy, and expense automation on roadmap.
a16z-backed enterprise SaaS and fintech.
Website All startups Funding news

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.